Latest filing published 26 Sept 2019 for Traws Pharma, Inc., €18k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -26.7%Entry US$2,081.25 · Close at T+365 US$1,526.25
- -80.4%Entry US$6,131.25 · Close at T+365 US$1,203.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tyndall Capital Partners L P: trading record in brief
Tyndall Capital Partners L P discloses dealings in Traws Pharma, Inc. to SEC (Form 4). Between 21 April 2017 and 24 September 2019, the trades on record add up to 15 filings.
On the open market, the record shows 2 purchases worth €4.5M and 12 sales worth €319k. The net balance comes to €4.1M on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. 2019 to date brings no purchases and 12 sales.
Most recently, on 26 September 2019, the filings show an open-market sale worth €18k in Traws Pharma, Inc. The last purchase on record was published on 1 May 2018, which is 3,114 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Tyndall Capital Partners L P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,700 shares@ US$1.190.5% of flowCommon StockSEC:0000905718-19-000789:0
- 75,119 shares@ US$1.622.8% of flowCommon StockSEC:0000905718-19-000785:0
- 37,242 shares@ US$1.231.1% of flowCommon StockSEC:0000905718-19-000785:1
- 49,995 shares@ US$2.102.5% of flowCommon StockSEC:0000905718-19-000781:0
- 1,247 shares@ US$2.750.1% of flowCommon StockSEC:0000905718-19-000775:0
- 400 shares@ US$2.770.0% of flowCommon StockSEC:0000905718-19-000773:0
- 400 shares@ US$2.750.0% of flowCommon StockSEC:0000905718-19-000753:0
- 5,015 shares@ US$2.780.3% of flowCommon StockSEC:0000905718-19-000753:1
- 8,185 shares@ US$2.840.5% of flowCommon StockSEC:0000905718-19-000596:0
- 2,742 shares@ US$2.810.2% of flowCommon StockSEC:0000905718-19-000596:1
- 1,458 shares@ US$3.450.1% of flowCommon StockSEC:0000905718-19-000579:0
- 1,380 shares@ US$3.400.1% of flowCommon StockSEC:0000905718-19-000557:0
- 10,147,058 shares@ US$0.42562.3% of flowCommon StockSEC:0000905718-18-000415:0Canonical exit: 26 Jul 2018 (T+90)
- 1,100,000 shares@ US$1.0115.8% of flowCommon StockSEC:0000905718-18-000125:0Canonical exit: 9 May 2018 (T+90)
- 476,190 shares@ US$2.1016.3% of flowCommon StockSEC:0000905718-17-000493:0
15 of 15 declarations